ArticleDiscover oncology2026

Pan-cancer analysis and experimental validation identify CYP19A1 as a prognostic biomarker and oncogenic driver associated with tumor immune microenvironment regulation in gastrointestinal cancers.

Zongrong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.